Pain Research and Treatment / 2014 / Article / Tab 5

Research Article

Clinical Characteristics, Patient-Reported Outcomes, and Previous Therapeutic Management of Patients with Uncontrolled Neuropathic Pain Referred to Pain Clinics

Table 5

Most common (≥5%) drugs for the treatment of neuropathic pain at the time of referral.

Drug% patientsMean dose (SD) mg/dayDuration (months) mean (SD)

Paracetamol21.22,398.6 (960.1)5.5 (6.3)
NSAIDs
 Ibuprofen17.91,428.4 (457.2)8.5 (13.3)
 Metamizol14.82,158.8 (1,598.7)8.5 (13.3)
 Diclofenac6.3124.9 (34.8)8.5 (13.3)
Opiods
 Tramadol27.1182.9 (110.1)12.1 (21.5)
 Fentanil8.618.5 (25.1)7.5 (12.9)
AED
 Pragabalin27.2244.6 (242.5)13.8 (17.4)
 Gabapentin19.01,297.7 (646.9)9.3 (12.0)
 Carbamazepine5.1577.1 (313.5)22.2 (27.5)
Antidepressants
 Amitriptyline10.836.2 (27.3)12.9 (15.4)
 Duloxetine6.158.3 (22.0)8.1 (8.0)
Other drugs
 Clonazepam5.72.1 (2.7)2.2 (1.0)

SD: standard deviation.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.